Publication | Open Access
Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer
51
Citations
27
References
2021
Year
We demonstrated that NEIL3 may serve as a diagnostic or therapeutic target for therapy-resistant patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1